Search
X T L Biopharmaceuticals Ltd
XTLBAdd to Watchlist
2.810USD
-0.040-1.40%
Close 07-31 16:00（ET）Quotes delayed by 15 min
6.19MMarket Cap
LossP/E TTM
More Details of X T L Biopharmaceuticals Ltd Company
X T L Biopharmaceuticals Ltd (Xenograft Technologies Ltd) is an Israel-based biopharmaceutical company engaged in acquisition and development of pharmaceutical drugs for treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong a survival of patients for treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by kidneys. EPO stimulates erythropoiesis, production of red blood cells, by binding to its receptor on a surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.
X T L Biopharmaceuticals Ltd Info
Ticker SymbolXTLB
Company nameX T L Biopharmaceuticals Ltd
IPO dateSep 01, 2000
CEOBand (Noam)
Number of employees- -
Security typeDepository Receipt
Fiscal year-endSep 01
Address5 Badner St., P.O.Box 8241
CityRAMAT GAN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code5218102
Phone97299557080
Websitehttps://www.xtlbio.com/
Ticker SymbolXTLB
IPO dateSep 01, 2000
CEOBand (Noam)
Company Executives of X T L Biopharmaceuticals Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Alexander Rabinovitch
Mr. Alexander Rabinovitch
Non-Executive Director
Non-Executive Director
365.35K
+54.74%
Mr. Doron Turgeman
Mr. Doron Turgeman
Non-Executive Director
Non-Executive Director
850.00
--
Mr. Shlomo Shalev
Mr. Shlomo Shalev
Chairman of the Board
Chairman of the Board
--
--
Ms. Osnat Hillel Fain
Ms. Osnat Hillel Fain
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Jonathan Schapiro
Dr. Jonathan Schapiro
Non-Executive Director
Non-Executive Director
--
--
Dr. Dobroslav Melamed
Dr. Dobroslav Melamed
Non-Executive Director
Non-Executive Director
--
--
Mr. Itay Weinstein
Mr. Itay Weinstein
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Iris Shapira Yalon
Ms. Iris Shapira Yalon
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Noam Band
Mr. Noam Band
Chief Executive Officer
Chief Executive Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Alexander Rabinovitch
Mr. Alexander Rabinovitch
Non-Executive Director
Non-Executive Director
365.35K
+54.74%
Mr. Doron Turgeman
Mr. Doron Turgeman
Non-Executive Director
Non-Executive Director
850.00
--
Mr. Shlomo Shalev
Mr. Shlomo Shalev
Chairman of the Board
Chairman of the Board
--
--
Ms. Osnat Hillel Fain
Ms. Osnat Hillel Fain
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Jonathan Schapiro
Dr. Jonathan Schapiro
Non-Executive Director
Non-Executive Director
--
--
Dr. Dobroslav Melamed
Dr. Dobroslav Melamed
Non-Executive Director
Non-Executive Director
--
--
FAQs
Who are the top five shareholders of X T L Biopharmaceuticals Ltd?
The top five shareholders of X T L Biopharmaceuticals Ltd are: Mr. Alexander Rabinovitch